Longitudinal Evaluation of Neutrophil-to-Lymphocyte Ratio in Guselkumab-Treated Patients with Psoriatic Disease and Levels of Systemic Inflammation Associated with Elevated Cardiovascular Risk: Post-hoc Analysis of 4 Phase 3, Randomized, Controlled Studies

被引:0
作者
Merola, Joseph [1 ]
Ogdie, Alexis [2 ]
Kavanaugh, Arthur [3 ]
Leibowitz, Evan [4 ]
Rampakakis, Emmanouil [5 ]
Funk, Ryan [6 ]
Nantel, Francois [7 ]
Lavie, Frederic [8 ]
Rowland, Katelyn [9 ]
Soriano, Enrique R. [10 ]
机构
[1] UT Southwestern Med Ctr, Newton, MA USA
[2] Univ Penn, Perelman Sch Med, Dept Med, Philadelphia, PA USA
[3] Univ Calif San Diego, La Jolla, CA USA
[4] Janssen Sci Affairs LLC, Fair Lawn, NJ USA
[5] McGill Univ, Dept Pediat Sci Affairs, JSS Med Res Inc, Montreal, PQ, Canada
[6] Johnson & Johnson Innovat Med, Long Grove, IL USA
[7] Nantel MedSci Consult, Montreal, PQ, Canada
[8] Janssen Cilag Global Med Affairs, Immunol Global Med Affairs, Issy Les Moulineaux, France
[9] Janssen Pharmaceut, Horsham, PA USA
[10] Hosp Italiano Buenos Aires, Buenos Aires, Argentina
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
2357
引用
收藏
页码:4760 / 4762
页数:3
相关论文
共 2 条
  • [1] The neutrophil-lymphocyte ratio and incident atherosclerotic events: analyses from five contemporary randomized trials
    Adamstein, Nicholas H.
    MacFadyen, Jean G.
    Rose, Lynda M.
    Glynn, Robert J.
    Dey, Amit K.
    Libby, Peter
    Tabas, Ira A.
    Mehta, Nehal N.
    Ridker, Paul M.
    [J]. EUROPEAN HEART JOURNAL, 2021, 42 (09) : 896 - 903
  • [2] Bhat T, 2013, EXPERT REV CARDIOVAS, V11, P55, DOI [10.1586/ERC.12.159, 10.1586/erc.12.159]